go-v.orgdoi

Advances in the Application of Immunohistochemical Markers in the Subtyping of Non-Small Cell Lung Cancer

Bohui Zhan, Cong Guo · Medical Research · 2026

  • DOI 10.6913/080301
  • Publisher OpenAlex
  • Type article
  • Issued 2026

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Medical Research · OpenAlex · article · 2026

Abstract

Lung cancer is the most common malignancy worldwide in terms of both incidence and mortality, with non-small cell lung cancer (NSCLC) accounting for approximately 80%–85% of all cases. As most patients are diagnosed at an advanced stage with limited biopsy material, hematoxylin and eosin (H&E) staining alone is often insufficient for precise histotyping. Immunohistochemistry (IHC), by detecting specific molecular markers, can significantly improve the accuracy and reproducibility of NSCLC subtyping.

This review systematically summarizes the diagnostic utility and expression characteristics of commonly used IHC markers—including TTF-1, Napsin A, Ki-67, CK7, CK5/6, p63, and p40—in the differential diagnosis between lung adenocarcinoma (ADC) and squamous cell carcinoma (SCC), and discusses the clinical strategies of multi-marker combinatorial testing. Current evidence indicates that the four-antibody panel combining TTF-1/Napsin A (for adenocarcinoma) and p40/CK5/6 (for squamous cell carcinoma) effectively distinguishes ADC from SCC, and is of great significance in guiding individualized therapy.

Open the resolved locator · 10.6913/080301

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 00:36 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://mrhk.cc/mrhk/article/view/174
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.